Comparison of Humoral Antibody Responses and Seroconversion Rates between Two Homologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination in Patients Undergoing Maintenance Hemodialysis.
Shih-Hsin HsiaoYuh-Mou SueChih-Chin KaoHui-Wen ChangYen-Chung LinChing-Sheng HungYi-Chen HsiehShiao-Ya HongChi-Li ChungJer-Hwa ChangYing-Shih SuMing-Che LiuKevin Shu-Leung LaiKo-Ling ChienJude Chu-Chun WangChung-Yi ChengTe-Chao FangPublished in: Vaccines (2023)
Our prospective, observational cohort indicates that a full prime-boost mRNA-1273 vaccination is likely to provide higher immune protection in hemodialysis patients compared to ChAdOx1, and this population with a prime-boost ChAdOx1 vaccination should be prioritized for a third dose.